… or intestine, can lead to systemic inflammation, which may aggravate or … inflammatory
diseases is low-grade systemic inflammation, usually characterised by increased pro-inflammatory …

… disease with prominent T H 17 inflammation. We also observed divergent responses to biologic
therapies targeting … protected lean mice but exacerbated disease in obese mice. Single-…

… plays a vital role in regulating inflammation. In this review, NLRP3 … in inflammatory diseases,
interactions with autophagy, and targeted therapeutic approaches in inflammatory diseases …

… is an important therapeutic target in inflammatory diseases. … in inflammatory diseases,
focusing on potential therapeutic applications of selective P2X7R antagonists as anti-inflammatory …

… inflammation. Cytokines may therefore be a logical target for inflammatory bowel disease
therapy … Biotechnology agents targeted against TNF, leukocyte adhesion, Th1 polarization, T …

… In conclusion, we focus on the therapeutic application of METTL3 in inflammatory diseases.
… inflammatory diseases will contribute to the development of improved targeted therapies and …

… the formation of proinflammatory mediators in ubiquitous inflammatory cascades has pushed
therapeutic strategies by targeting pCRP dissociation in inflammation. In this respect, the …

… Inflammatory disease management poses challenges due to the complexity of inflammation
… simultaneous imaging and treatment of inflammatory diseases. Theranostics could facilitate …

… models of immune inflammatory disease. This endogenous anti-inflammatory protein
could serve as the basis for novel approaches to therapy of similar conditions in humans. …

… acute and chronic inflammatory diseases. Our results … therapy for NLRP3-dependent
inflammatory diseases. Our study also provided an example for treating immune-related diseases …